A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...
5don MSN
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.
Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...
Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in ...
A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and ...
6d
PsyPost on MSNOzempic blindness? Serious vision problems reported in patients taking weight loss medicationsA new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...
"We are honored to be recognized as a top-performing company in the 2025 TSX Venture 50," said Shane Madden, CEO of Hydreight Technologies. "This achievement reflects our continued commitment to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results